Madrid invests almost 3 million in 60,500 children's vaccines against measles and hepatitis B

The Community of Madrid has authorized the acquisition of doses to protect the child population against diseases such as measles, chickenpox, and hepatitis B, as part of the vaccination schedule.

Generic image of a children's vaccine.
IA

Generic image of a children's vaccine.

The Community of Madrid has approved an investment of almost 3 million euros to acquire 60,500 doses of children's vaccines, aimed at protecting minors against diseases such as measles, rubella, mumps, chickenpox, and hepatitis B, integrating them into the regional vaccination schedule.

The Governing Council of the Community of Madrid has greenlighted the tender for a contract that will allow the purchase of these vaccines. This operation is part of a Framework Agreement for supply that covers the entire National Health System, ensuring the availability of the necessary doses for the child population in Madrid.
Of the total of 60,500 doses that Madrid's public health system will acquire, 56,000 correspond to the quadrivalent vaccine, which offers protection against measles, rubella, mumps, and chickenpox. The remaining doses will be allocated to immunization against hepatitis B, a disease also included in essential vaccination guidelines.
These vaccines will be administered following the Lifelong Vaccination Schedule of the Ministry of Health, a program that establishes immunization guidelines for both childhood and adulthood. Vaccination is considered by the Community of Madrid as the most effective preventive measure to control and eradicate the transmission of various diseases.
Madrid's health authorities emphasize that childhood vaccination is one of the most consolidated strategies for protection against vaccine-preventable diseases. They highlight the importance of completing all required doses and administering them at the appropriate time, according to the current schedule, which is reviewed and updated annually to incorporate the latest scientific advances in immunization.